{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:44:44Z","timestamp":1790790284066,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","prd-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.parkreldis.2016.05.031","type":"journal-article","created":{"date-parts":[[2016,5,31]],"date-time":"2016-05-31T00:35:39Z","timestamp":1464654939000},"page":"47-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"special_numbering":"C","title":["Functional neuroimaging and clinical features of drug naive patients with de novo Parkinson\u2019s disease and probable RBD"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6823-6069","authenticated-orcid":false,"given":"Dario","family":"Arnaldi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Morbelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Brugnolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Girtler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnese","family":"Picco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Ferrara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Accardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambra","family":"Buschiazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"de Carli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Pagani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Nobili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2016.05.031_bib1","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2016.05.031_bib2","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/ana.24261","article-title":"Prioritized research recommendations from the national institute of neurological disorders and stroke Parkinson\u2019s disease 2014 conference","volume":"76","author":"Sieber","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2016.05.031_bib3","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/jamaneurol.2015.0703","article-title":"New clinical subtypes of Parkinson disease and their longitudinal progression: a prospective cohort comparison with other phenotypes","volume":"72","author":"Fereshtehnejad","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.parkreldis.2016.05.031_bib4","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/mds.24957","article-title":"REM sleep behavior disorder: motor manifestations and pathophysiology","volume":"27","author":"Arnulf","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2016.05.031_bib5","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/brain\/123.2.331","article-title":"Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases","volume":"123","author":"Olson","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2016.05.031_bib6","series-title":"International Classification of Sleep Disorders","author":"AASM","year":"2014"},{"key":"10.1016\/j.parkreldis.2016.05.031_bib7","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.sleep.2013.02.016","article-title":"Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy-a consensus statement from the international rapid eye movement sleep behavior disorder study group","volume":"14","author":"Schenck","year":"2013","journal-title":"Sleep. Med."},{"key":"10.1016\/j.parkreldis.2016.05.031_bib8","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/mds.20719","article-title":"REM sleep behavior disorder, hallucinations, and cognitive impairment in Parkinson\u2019s disease","volume":"21","author":"Sinforiani","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2016.05.031_bib9","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/mds.25086","article-title":"Rapid eye movement sleep behavior disorder and subtypes of Parkinson\u2019s disease","volume":"27","author":"Romenets","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2016.05.031_bib10","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1016\/j.neurobiolaging.2015.08.025","article-title":"Nigro-caudate dopaminergic deafferentation: a marker of REM sleep behavior disorder?","volume":"36","author":"Arnaldi","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.parkreldis.2016.05.031_bib11","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1038\/jcbfm.2015.173","article-title":"Assessing cerebral glucose metabolism in patients with idiopathic rapid eye movement sleep behavior disorder","volume":"35","author":"Ge","year":"2015","journal-title":"J.\u00a0Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.parkreldis.2016.05.031_bib12","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.tins.2009.06.003","article-title":"Metabolic brain networks in neurodegenerative disorders: a functional imaging approach","volume":"32","author":"Eidelberg","year":"2009","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.parkreldis.2016.05.031_bib13","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1212\/WNL.0000000000000130","article-title":"Abnormal metabolic network activity in REM sleep behavior disorder","volume":"82","author":"Holtbernd","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2016.05.031_bib14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archneur.56.1.33","article-title":"Diagnostic criteria for Parkinson disease","volume":"56","author":"Gelb","year":"1999","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.parkreldis.2016.05.031_bib15","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1056\/NEJM198910053211407","article-title":"Orthostatic hypotension in the elderly","volume":"321","author":"Lipsitz","year":"1989","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.parkreldis.2016.05.031_bib16","first-page":"145","article-title":"Smell diskettes as screening test of olfaction","volume":"37","author":"Briner","year":"1999","journal-title":"Rhinology"},{"key":"10.1016\/j.parkreldis.2016.05.031_bib17","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.sleep.2010.12.009","article-title":"Validation of the Mayo Sleep Questionnaire to screen for REM sleep behavior disorder in an aging and dementia cohort","volume":"12","author":"Boeve","year":"2011","journal-title":"Sleep. Med."},{"key":"10.1016\/j.parkreldis.2016.05.031_bib18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/mds.22899","article-title":"Cognitive-nigrostriatal relationships in de novo, drug-naive Parkinson\u2019s disease patients: a [I-123]FP-CIT SPECT study","volume":"25","author":"Nobili","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2016.05.031_bib19","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/mds.24893","article-title":"Diagnostic criteria for mild cognitive impairment in Parkinson\u2019s disease: movement disorder society task force guidelines","volume":"27","author":"Litvan","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2016.05.031_bib20","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00259-009-1267-x","article-title":"EANM procedure guidelines for brain neurotransmission SPECT using (123)I-labelled dopamine transporter ligands, version 2","volume":"37","author":"Darcourt","year":"2010","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.parkreldis.2016.05.031_bib21","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00259-012-2304-8","article-title":"Automatic semi-quantification of [123I]FP-CIT SPECT scans in healthy volunteers using BasGan version 2: results from the ENC-DAT database","volume":"40","author":"Nobili","year":"2013","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.parkreldis.2016.05.031_bib22","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s00259-009-1264-0","article-title":"EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2","volume":"36","author":"Varrone","year":"2009","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.parkreldis.2016.05.031_bib23","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1016\/j.neurobiolaging.2012.01.005","article-title":"Resting metabolic connectivity in prodromal Alzheimer\u2019s disease. A European Alzheimer Disease Consortium (EADC) project","volume":"33","author":"Morbelli","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.parkreldis.2016.05.031_bib24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.cpet.2013.10.006","article-title":"Brain: normal variations and benign findings in fluorodeoxyglucose-PET\/computed tomography imaging","volume":"9","author":"Berti","year":"2014","journal-title":"PET Clin."},{"key":"10.1016\/j.parkreldis.2016.05.031_bib25","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1212\/WNL.0000000000000792","article-title":"Functional pattern of brain FDG-PET in amyotrophic lateral sclerosis","volume":"83","author":"Pagani","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2016.05.031_bib26","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000189269","article-title":"Parkinson\u2019s disease with and without REM sleep behaviour disorder: are there any clinical differences?","volume":"61","author":"Yoritaka","year":"2009","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.parkreldis.2016.05.031_bib27","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/mds.26350","article-title":"Probable RBD and association with neurodegenerative disease markers: a population-based study","volume":"30","author":"Mahlknecht","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2016.05.031_bib28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/ana.21680","article-title":"Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson\u2019s disease","volume":"66","author":"Gagnon","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2016.05.031_bib29","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1212\/WNL.0b013e3181d55f61","article-title":"Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in\u00a0vivo","volume":"74","author":"Klein","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2016.05.031_bib30","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/ana.22691","article-title":"Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease","volume":"71","author":"Kotagal","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2016.05.031_bib31","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.neuroimage.2007.12.057","article-title":"Normalization in PET group comparison studies\u2013the importance of a valid reference region","volume":"40","author":"Borghammer","year":"2008","journal-title":"Neuroimage"},{"key":"10.1016\/j.parkreldis.2016.05.031_bib32","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1212\/WNL.0000000000002437","article-title":"Development and external validation of a prognostic model in newly diagnosed Parkinson disease","volume":"86","author":"Velseboer","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2016.05.031_bib33","doi-asserted-by":"crossref","first-page":"475","DOI":"10.5664\/jcsm.2670","article-title":"Validation of the Mayo Sleep Questionnaire to screen for REM sleep behavior disorder in a community-based sample","volume":"9","author":"Boeve","year":"2013","journal-title":"J.\u00a0Clin. Sleep. Med."}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802016301936?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802016301936?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T09:59:11Z","timestamp":1600682351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802016301936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":33,"alternative-id":["S1353802016301936"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2016.05.031","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional neuroimaging and clinical features of drug naive patients with de novo Parkinson\u2019s disease and probable RBD","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2016.05.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}